Logo
Search

Rules:

Only words with 2 or more characters are accepted
Max 200 chars total
Space is used to split words, "" can be used to search for a whole string (not indexed search then)
AND, OR and NOT are prefix words, overruling the default operator
+/|/- equals AND, OR and NOT as operators.
All search words are converted to lowercase.

Search for "qt"

Displaying results 1 to 9 out of 9

  Info-Point 81%
  ... Scientific Publications / White Papers Poster Effect of Multiple Oral Doses of NOMAC/E2 on QTcF Intervals  News / Press Releases Press release Management Buy-Out at CRS Pressemitteilung ... Patients Flyer Aging Population - A Challenge In Drug Development Today Flyer Thorough QT/TQT Study – in the Hands of Professionals   Flyer Your Medical Device - Clinical Investigation ...
  Size: 38 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Info-Point

  In a Nutshell 78%
  ... and patients'. Please feel free to contact CRS directly. Special Fields of Expertise Interaction trials (food, drug & genotype) Thorough QT / QTc Renal & hepatic impairment Respiratory / inhalative devices Women's health / gynaecological examinations Men's health Dermal & transdermal ...
  Size: 31 K - Created: 12-08-15 - Modified: 20-12-17 11:58
Path: /CRS/In a Nutshell

  Services 76%
  ... trials. The service panel of CRS in phase I-II human pharmacological trials includes BE/BA, FIM, POC, patient trials and specialties like QTc and renal/hepatic insufficiency. The in-house modular services Consultancy, Clinical Data Management (CDM), Statistical Analysis (STAT), ...
  Size: 29 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Services

  Trial Expertise 71%
  ... to therapeutic drugs, CRS has access to a broad range of genotyped subjects . Thorough QTc/cardiac safety CRS has conducted 19 trials with cardiac safety monitoring and central ECG evaluation. Twelve of these studies have been TQT trials pursuant to ICH E14. CRS has cooperated with all relevant core labs (eRT, Ganimed, ... trial designs (ambulatory, hospitalized, mixed) and various blinding and dummy procedures. T
  Size: 35 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Expertise/Trial Expertise

  Mönchengladbach 69%
  ... performance of human pharmacology trials in all standard designs. CRS-Mönchengladbach is dedicated to implementing large-scale trials such as QTc (more than 150 subjects) and long-term trials (overnight stays up to 46 days) combined with challenging PK and PD schedules. In addition, the ...
  Size: 31 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Locations/Mönchengladbach

  Mannheim 65%
  ... of this unit include clinical pharmacology trials in all standard designs. This unit is dedicated to conducting large-scale trials such as QTc (more than 200 subjects) and long-term trials (overnight stays up to 56 days). Additionally, the unit has special expertise including ...
  Size: 33 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Locations/Mannheim

  2010-2018 64%
  ... a sustained follicle stimulant, do not prolong the QTcF-interval in healthy postmenopausal volunteers. Int ... on the ECG of healthy subjects: an ICH E14 thorough QT trial. Springerplus. 2014 Jul 29;3:389. doi: ... of Nomegestrol Acetate (NOMAC)/17?-Estradiol (E2) on QTcF Intervals in Healthy Women: Results from a ... Estradiol and Estrone and their relationship on
  Size: 66 K - Created: 09-11-15 - Modified: 17-07-18 09:33
Path: /Expertise/Published Expertise/2010-2018

  2000 – 2009 47%
  ... Pharmacology (VkliPha 2008), November 6-8, 2008, Berlin. Timmer W. Cardiac Safety – Dr Wolfgang Timmer of CRS examines the conduct of thorough QTc trials in practice from a Phase I CRO's perspective. European Pharmaceutical Contractor 2008; (Summer 08). Timmer W. Minimising risk by ...
  Size: 53 K - Created: 09-11-15 - Modified: 20-12-17 11:58
Path: /Expertise/Published Expertise/2000 – 2009

  1990 – 1999 44%
  ... metrifonate in patients with renal impairment. Ther Drug Monit 1999 ; 21(3):310-316. Eckl KM, Thomsen T , Römer A, Dehn A. Terfenadine induced QTc-Prolongation in healthy subjects - a safety model. Eur J Clin Pharmacol 1999 ; 55 (No. 108). Rost KL, Fuhr U, Thomsen T , Zaigler M, ...
  Size: 61 K - Created: 18-11-12 - Modified: 20-12-17 11:58
Path: /Expertise/Published Expertise/1990 – 1999

FooterEnd